Hinton W, Ansari AS, Whyte MB, McGovern AP, et al. Sodium-glucose co-transporter-2 (SGLT2) inhibitors in type 2 diabetes: are clinical trial benefits for heart failure reflected in real-world clinical practice? A systematic review and meta-analysis of observational studies. Diabetes Obes Metab 2022 Oct 14. doi: 10.1111/dom.14893.
PMID: 36239122